Sort
53,477 grants matching “addiction”
Chronic Alcohol and Brain Stress Circuit Response
$586,557Rajita Sinha · Yale University · R01 · FY2010 · AA
Biomarkers of toxic response to low nicotine cigarette smoke
$586,544Ian Alexander Blair · University Of Pennsylvania · R01 · FY2010 · CA
Akt/GSK-3 Signaling Cascade and the Actions of Dopamine
$586,469Marc G. Caron · Duke University · R37 · FY2015 · MH
A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI)
$586,419Shivanand P Lad · Duke University · UH3 · FY2025 · NS
Molecular Neurobiology of Human Opioid Use Disorder
$586,397Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA
Development, Ecology, and Prevention of Adult Addictive Behavior
$586,318Thomas J Dishion · Arizona State University-Tempe Campus · R01 · FY2014 · DA
Laboratory Model for Heroin Abuse Medications
$586,313Sandra D. Comer · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P50 · FY2007 · DA
Time Horizons and the Behavioral Economics of Recovery from Drinking Problems
$586,284Jalie A Tucker · University Of Alabama At Birmingham · R01 · FY2011 · AA
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
$586,271David Fiellin · Yale University · R01 · FY2007 · DA
Administrative Core
$586,269Kimberly Kirkpatrick · Kansas State University · P20 · FY2022 · GM
Mechanisms underlying the influence of stress on drug-seeking behavior
$586,247John R Mantsch · Medical College Of Wisconsin · R01 · FY2023 · DA
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse
$586,232Joan Weinberger Berman · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · DA
CNS Effects of Alcohol-Gene Expression
$586,169Scripps Research Institute · R01 · FY2005 · AA
TRAINING A NEW GENERATION OF CAM CLINICAL INVESTIGATORS
$586,158Minneapolis Medical Research Fdn, Inc. · T32 · FY2005 · AT
Medication for Opioid Use Disorder, Predictability of Retention vs Attrition
$586,143Philip Todd Korthuis · Oregon Health & Science University · UG1 · FY2022 · DA
Expanding Treatment of Opioid Dependence Among the Privately Insured
$586,064Susan H Busch · Yale University · R01 · FY2010 · DA
Informing anti-tobacco communications with affective and decision science: Application of the Appraisal Tendency Framework
$586,021Vaughan W. Rees · Harvard School Of Public Health · R01 · FY2022 · CA
Using NIATx Strategies to Implement Integrated Services in Routine Care
$586,019Mark P. McGovern · Dartmouth College · R01 · FY2015 · DA
Discovery and functional characterization of long non-coding RNAs in opioid use disorder within the context of HIV at single cell resolution
$585,975Chan Zhou · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · DA
Tailored Youth Drug Intervention in Primary Care
$585,961Frederic C Blow · University Of Michigan At Ann Arbor · R01 · FY2008 · DA
Genomic Predictors of Placebo response in Phase II AUD trials
$585,949Chamindi Seneviratne · University Of Maryland Baltimore · R01 · FY2019 · AA
Epigenetic Determinants Influencing Development and Evolution of Chronic Post-surgical Pain in Children Undergoing Musculoskeletal Surgery.
$585,931Vidya Chidambaran · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · AR
NEUROBIOLOGY OF REINFORCEMENT, CRAVING AND RELAPSE
$585,893Yale University · P01 · FY2000 · DA
CORE--BEHAVIORAL
$585,893Yale University · P01 · FY2000 · DA
CORE--TRANSGENIC
$585,893Yale University · P01 · FY2000 · DA